GlassScriptPhysician profile
Krystle Phillips
NPI 1831633098
$3,830.54
in general payments reported to CMS, 2019-2025
34 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $605 · 2022: $1,172 · 2023: $1,310 · 2024: $537 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,053.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $657.92 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $482.86 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $446.29 | 2022-2023 | Erleada, Akeega |
| Urovant Sciences INC | $216.71 | 2021-2022 | |
| Pfizer INC. | $215.81 | 2021-2024 | |
| Astellas Pharma US INC | $198.91 | 2021-2024 | Xtandi, Myrbetriq |
| Axonics, INC. | $162.15 | 2022-2023 | Axonics |
| Teleflex LLC | $137.64 | 2021 | |
| Ethicon US, LLC | $137.50 | 2022 | |
| Progenics Pharmaceuticals, INC. | $134.88 | 2023-2024 | Pylarify |
| Tolmar, INC. | $132.37 | 2023-2024 | |
| Halozyme INC | $92.40 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.83 | 2022-2023 | |
| Myovant Sciences INC. | $76.32 | 2021-2022 | |
| Rochester Medical Corporation | $74.13 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $59.10 | 2022 | |
| Olympus America INC. | $58.23 | 2023-2025 | Itind System |
| Coloplast Corp | $54.19 | 2022-2023 | Speedicath |
| Merck Sharp & Dohme LLC | $49.33 | 2022-2023 | Keytruda, Welireg, Lynparza |
| Tolmar Pharmaceuticals, INC. | $42.50 | 2022 | |
| Immunitybio, INC. | $41.74 | 2025 | Anktiva |
| Urogen Pharma, INC. | $31.23 | 2023 | Jelmyto |
| Mission Pharmacal Company | $30.90 | 2021-2022 | |
| 180 Medical, INC. | $29.96 | 2022 | |
| Dendreon Pharmaceuticals LLC | $27.47 | 2021 | |
| Procept Biorobotics Corporation | $26.65 | 2023 | Aquabeam Robotic System |
| Myriad Genetic Laboratories, INC. | $21.90 | 2024 | Prolaris |
| Medtronic, INC. | $19.38 | 2021 | |
| Endo Pharmaceuticals INC. | $18.51 | 2022 | |
| Hollister Incorporated | $16.82 | 2023 | Infyna Chic |
| Boston Scientific Corporation | $14.63 | 2024 | Ams 700 |
| Kowa Pharmaceuticals America, INC. | $14.01 | 2023 | Seglentis |
| Photocure INC | $12.76 | 2023 | Cysview |
| Travere Therapeutics, INC. | $5.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krystle Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.